Skip to main content
. Author manuscript; available in PMC: 2013 Apr 24.
Published in final edited form as: Ann Emerg Med. 2011 Jul 29;58(6):551–558.e2. doi: 10.1016/j.annemergmed.2011.07.001

Table I.

Characteristics of the Study Cohort

Characteristics Total Cohort
(N=475,829)
Survived
(N=475,472)
Death within 7 days
(N=357)
Age
 18-39 182,310 182,295 (38.3) 15 (4.2)
 40-59 172,136 172,073 (36.2) 63 (17.7)
 60-79 96,256 96,093 (20.2) 163 (45.7)
 80+ 25,127 25,011 (5.3) 116 (32.5)
Gender
 Female 272,825 272,671 (57.4) 154 (43.1)
Race/Ethnicity
 White 167,713 167,521 (35.2) 192 (53.8)
 Asian/PI 34,942 34,929 (7.4) 13 (3.6)
 Black 65,378 65,302 (13.7) 76 (21.3)
 Hispanic 170,921 170,850 (35.9) 71 (19.9)
 Other/Unknown 36,875 36,870 (7.8) 5 (1.4)
Household income1
 <=38611 93,488 93,426 (19.7) 62 (17.4)
 38612-50738 93,679 93,612 (19.7) 67 (18.8)
 50739-63548 93,534 93,465 (19.7) 69 (19.3)
 63549-81840 93,648 93,568 (19.7) 80 (22.4)
 81841+ 93,507 93,429 (19.7) 78 (21.9)
 Unknown 7,973 7,972 (1.7) 1 (0.3)
Comorbidity
 Myocardial infarction 22,089 21,999 (4.6) 90 (25.2)
 Congestive heart failure 21,952 21,818 (4.6) 134 (37.5)
 Peripheral vascular
 disease
15,305 15,213 (3.2) 92 (25.8)
 Cerebrovascular disease 28,000 27,885 (5.9) 115 (32.2)
 Dementia 2,665 2,642 (0.6) 23 (6.4)
 Chronic pulmonary
 disease
95,394 95,246 (20) 148 (41.5)
 Rheumatologic disease 9,772 9,745 (2.1) 27 (7.6)
 Pepticulcer disease 4,065 4,049 (0.9) 16 (4.5)
 Mild liver disease 2,952 2,944 (0.6) 8 (2.2)
 Diabetes 32,822 32,786 (6.9) 36 (10.1)
 Diabetes with chronic
 complications
3,7489 37,377 (7.9) 112 (31.4)
 Hemiplegia or paraplegia 4,952 4,925 (1.0) 27 (7.6)
 Renal disease 39,126 38,970 (8.2) 156 (43.7)
 Any (primary) malignancy 25,584 25,520 (5.4) 64 (17.9)
 Moderate or severe liver
 disease
1,687 1,678 (0.4) 9 (2.5)
 Metastatic solid tumor 8,127 8,068 (1.7) 59 (16.5)
 AIDS 1,520 1,519 (0.3) 1 (0.3)
1

Presented in quintiles